MAHA’s internal rifts and financial ties threaten Kennedy’s health agenda ahead of midterms

Key points

• MAHA is experiencing a sharp divide between its grassroots founders, who feel the movement has been co-opted by corporate interests, and mainstream Republicans who fear its anti-vaccine rhetoric will hurt candidates in close races.
• Kennedy’s latest financial disclosure reveals $4 million in book advances from a publisher owned by a close associate who also manages MAHA-related entities, raising questions about federal ethics rules.
• The movement’s political viability will be tested in the Iowa governor’s race, where Kennedy-backed candidate Zach Lahn is receiving $1 million in funding, though Kennedy’s stance on glyphosate has alienated some supporters.
• Recent regulatory setbacks, including the FDA’s reversal on mRNA flu vaccines and the approval of flavored e-cigarettes, have strained Kennedy’s relationship with the White House and key allies like former FDA commissioner Marty Makary.

Background

MAHA began as a grassroots health crusade focused on wellness and skepticism of vaccines and ultra-processed foods before becoming an official government policy initiative under Kennedy’s leadership as Health Secretary. The movement has since expanded into a political fundraising arm, raising contributions and supporting Republican candidates across the country. Kennedy, who is the most popular secretary in Trump’s cabinet according to Pew Research, has traveled to battleground states to campaign for the party, though his rhetoric has created tensions with mainstream Republicans.

How outlets are covering it

The Financial Times emphasizes the internal split within MAHA, highlighting how grassroots supporters feel the movement has been hijacked by corporate interests, while mainstream Republicans worry that Kennedy’s anti-vaccine stance could endanger party candidates in close races. The New York Times focuses on the ethical implications of Kennedy’s financial disclosures, noting that the $4 million in book advances and other gifts from close allies may violate federal rules barring officials from profiting from their government position. Both outlets agree that these issues pose significant risks to MAHA’s political viability, but they frame the problem differently: the FT sees it as a movement-level crisis, while the NYT sees it as a personal ethics issue for Kennedy.

Why it matters

The internal divisions and ethical concerns surrounding MAHA could undermine its ability to influence the 2026 midterm elections, particularly in key races like the Iowa governor’s contest. If Kennedy’s anti-vaccine rhetoric alienates mainstream Republicans, it could cost the party support in close races. Additionally, the financial ties between Kennedy and MAHA-related entities raise questions about the impartiality of his decision-making as Health Secretary, potentially eroding public trust in the administration’s health policies.

What to watch

The next major test for MAHA will be the September 29 health conference in Washington, where nine public companies are scheduled to speak, including AI firms OpenAI and Anthropic, and insurance company UnitedHealth. The outcome of the Iowa governor’s race in November will also be a key indicator of MAHA’s political viability. Kennedy’s ability to navigate the tensions between grassroots supporters and corporate sponsors, as well as his relationship with the White House, will determine whether MAHA can maintain its influence in the coming years.